Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Możliwość wyrażenia dobrowolnej, pisemnej zgody na udział w badaniu
- •Umiejętność komunikacji w języku angielskim (czytanie, pisanie, mówienie, rozumienie)
- •Przebyta operacja usunięcia macicy lub planowana taka operacja
- •Identyfikacja jako osoba transpłciowa lub o innej tożsamości płciowej
✗ Disqualifies
- •Rezygnacja z udziału w badaniu
- •Wiek poniżej 18 lat
- •Brak zdolności do wyrażenia świadomej zgody
- •Członkowie zespołu doradczego badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 16, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University of Minnesota
Minneota, United States
Trial contact
Samantha Hoffman, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/17/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.